GlassScriptPhysician profile
Charlene S Scott
NPI 1144399080
$839.92
in general payments reported to CMS, 2019-2025
17 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.95 · 2021: $11.69 · 2022: $51.28 · 2023: $182 · 2024: $314 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $275.46 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $100.13 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $78.45 | 2019-2025 | |
| Lilly USA, LLC | $71.22 | 2023-2024 | Jardiance, Mounjaro, Emgality |
| Abbvie INC. | $67.67 | 2024-2025 | |
| Glaxosmithkline, LLC. | $35.01 | 2023-2024 | Shingrix |
| Daiichi Sankyo INC. | $24.97 | 2023 | Injectafer |
| Grifols USA, LLC | $24.10 | 2024 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $21.96 | 2023 | |
| Hologic Sales and Service, LLC | $19.58 | 2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $19.56 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.33 | 2024 | Jardiance, Synjardy |
| Exact Sciences Corporation | $18.13 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $17.39 | 2025 | Farxiga |
| Insulet Corporation | $17.16 | 2025 | Omnipod |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.96 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $13.84 | 2025 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlene Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.